The results demonstrated that the mRNA level of CHK1 in HCC was significantly decreased after treatment with Tibetan medicine Liuweimuxiang Pills compared to the control group (p < 0.001; Supplementary Material Figure S6). This evidence concerns the gene CHEK1 and hepatocellular carcinoma.